Abstract
A 32-year-old man with CML in second chronic phase developed primary graft failure following matched unrelated donor transplantation using cryopreserved marrow cells. He was successfully regrafted within 60 days from a second fully matched donor using a non-myeloablative conditioning regimen, with minimal toxicity. He remains in complete haematological, cytogenetic and molecular remission 2 years after second transplant. We believe that reduced intensity or ‘mini-transplants’ may be preferable for patients requiring second allografts which are usually associated with a high transplant-related mortality. Bone Marrow Transplantation (2001) 27, 547–549.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kernan NG, Bartsch G, Ash R et al. Retrospective analysis of 462 unrelated marrow transplants facilitated by the National Marrow Donor Program for the treatment of acquired and congenital disorders of the lymphohematopoietic system and congenital metabolic disorders New Engl J Med 1993 328: 593–602
Ash R, Casper J, Chitambar C et al. Successful allogeneic transplantation of T-cell depleted bone marrow from closely HLA-matched unrelated donors New Engl J Med 1990 322: 485–494
McGlave P, Shu Z, Wen W et al. Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years’ experience of the National Marrow Donor Program Blood 2000 95: 2219–2226
Beatty P, Clift R, Mickelson E et al. Marrow transplantation from related donors other than HLA-identical siblings New Engl J Med 1985 313: 765–771
Gingrich R, Howe C, Goeken N et al. Successful bone marrow transplantation with partially matched unrelated donors Transplant Proc 1985 17: 450–452
Storb R, Prentice R, Thomas E et al. Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anemia Br J Haematol 1983 55: 573–585
Martin P, Hansen J, Buckner C et al. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts Blood 1985 66: 664–672
Grandage V, Cornish J, Pamphilon D et al. Second allogeneic bone marrow transplants from unrelated donors for graft failure following initial unrelated donor bone marrow transplantation Bone Marrow Transplant 1998 21: 687–690
Mrsic M, Horowitz M, Atkinson K et al. Second HLA-identical sibling transplants for leukemic recurrence Bone Marrow Transplant 1992 9: 269–275
Estey E, Thall P, Andreeff M et al. Use of granulocyte colony stimulating factor before, during and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony stimulating factor J Clin Oncol 1994 12: 671–678
Byrne J, Stainer C, Cull G et al. The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor transplantation for leukaemia Bone Marrow Transplant 2000 25: 411–417
Stockschlader M, Kruger W, Kroschke G et al. Use of cryopreserved bone marrow in allogeneic bone marrow transplantation Bone Marrow Transplant 1995 15: 569–572
Mehta J, Powles R, Singhal S et al. Outcome of autologous rescue after failed engraftment of allogeneic marrow Bone Marrow Transplant 1996 17: 213–217
Remberger M, Ringden O, Ljungman P et al. Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation Bone Marrow Transplant 1998 22: 73–78
Pawson R, Macdonald I, Potter M et al. Fludarabine based conditioning (‘mini-transplant’) for second allograft in acute leukaemia Br J Haematol 1999 105: (Suppl. 1) 132a
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Byrne, J., Musuka, C., Davy, B. et al. Successful engraftment of a second transplant using non-myeloablative conditioning as treatment for graft failure following unrelated donor BMT. Bone Marrow Transplant 27, 547–549 (2001). https://doi.org/10.1038/sj.bmt.1702825
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702825